series-a
Stage
2
Investors
About
Trillium Therapeutics is a clinical-stage immuno-oncology company developing therapies that target the innate immune system to treat hematologic cancers and solid tumors.
Explore Trillium Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.